Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Orphan Drugs, 49722 [E7-17094]
Download as PDF
<![CDATA[
49722
Federal Register / Vol. 72, No. 167 / Wednesday, August 29, 2007 / Notices
Reason: Failed to maintain a valid
bond.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sandra L. Kusumoto,
Director, Bureau of Certification and
Licensing.
[FR Doc. E7–17139 Filed 8–28–07; 8:45 am]
Centers for Disease Control and
Prevention
Food and Drug Administration
Board of Scientific Counselors,
National Center for Health Statistics
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Orphan Drugs
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License Applicants
Notice is hereby given that the
following applicants have filed with the
Federal Maritime Commission an
application for license as a Non-Vessel
Operating Common Carrier and Ocean
Freight Forwarder—Ocean
Transportation Intermediary pursuant to
section 19 of the Shipping Act of 1984
as amended (46 U.S.C. Chapter 409 and
46 CFR part 515).
Persons knowing of any reason why
the following applicants should not
receive a license are requested to
contact the Office of Transportation
Intermediaries, Federal Maritime
Commission, Washington, DC 20573.
Non-Vessel Operating Common Carrier
Ocean Transportation Intermediary
Applicant
Jeepney Express Padala, Inc. dba
Jeepney Express; Kalesa Express;
Victory Cargo, 2647 West Woodland
Drive, Anaheim, CA 92801. Officers:
Edna Cabal Quinto, Treasurer
(Qualifying Individual), Gregorio
Sycip, President.
Non-Vessel Operating Common Carrier
and Ocean Freight Forwarder
Transportation Intermediary Applicant
One Arrow, LLC, 12900 Griffing Blvd.,
Miami, FL 33161. Officer: Emmanuel
Nwankwo, President (Qualifying
Individual).
Ocean Freight Forwarder—Ocean
Transportation Intermediary Applicant
jlentini on PROD1PC65 with NOTICES
Victoria Shipping, 104 Bald Knob Road,
Wetumpka, AL 36092. Susan V.
Hagan, Sole Proprietor.
Dated: August 24, 2007.
Karen V. Gregory,
Assistant Secretary.
[FR Doc. E7–17128 Filed 8–28–07; 8:45 am]
BILLING CODE 6730–01–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS)
announces the following meeting of the
aforementioned committee.
Times and Dates: 2 p.m.–5:30 p.m.,
September 17, 2007. 8:30 a.m.–2 p.m.,
September 18, 2007.
Place: NCHS Headquarters, 3311 Toledo
Road, Hyattsville, Maryland 20782.
Status: Open to the public, and limited
only to the space available. The meeting
room accommodates approximately 100
people.
Purpose: This committee is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human Services;
the Director, CDC; and the Director, NCHS,
regarding the scientific and technical
program goals and objectives, strategies, and
priorities of NCHS.
Matters To Be Discussed: The agenda will
include welcome remarks by the Director,
NCHS; introduction of new chair and new
members and key NCHS staff; data access
discussions; discussion of the upcoming
review of the SLAITS program; discussion of
upcoming program reviews and an open
session for comments from the public.
Requests to make oral presentations should
be submitted in writing to the contact person
listed below. All requests must contain the
name, address, telephone number, and
organizational affiliation of the presenter.
Written comments should not exceed five
single-spaced typed pages in length and must
be received by September 10, 2007.
The agenda items are subject to change as
priorities dictate.
For Further Information Contact: Virginia
S. Cain, Ph.D., Director of Extramural
Research, NCHS/CDC, 3311 Toledo Road,
Room 7211, Hyattsville, Maryland 20782,
telephone (301) 458–4500, fax (301) 458–
4020.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: August 22, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–17137 Filed 8–28–07; 8:45 am]
BILLING CODE 4163–18–P
VerDate Aug<31>2005
16:04 Aug 28, 2007
Jkt 211001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
[Docket No. 2006N–0420]
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Orphan Drugs’’ has been approved by
the Office of Management and Budget
(OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In the
Federal Register of May 29, 2007 (72 FR
29515), the agency announced that the
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0167. The
approval expires on August 31, 2010. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
Dated: August 23, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–17094 Filed 8–28–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007D–0310]
Companion to Guidance for Industry
on Pharmacogenomic Data;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 72, Number 167 (Wednesday, August 29, 2007)]
[Notices]
[Page 49722]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-17094]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0420]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Orphan Drugs
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Orphan Drugs'' has been approved
by the Office of Management and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief
Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In the Federal Register of May 29, 2007 (72
FR 29515), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0167.
The approval expires on August 31, 2010. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.fda.gov/ohrms/dockets.
Dated: August 23, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-17094 Filed 8-28-07; 8:45 am]
BILLING CODE 4160-01-S
